Lisa M Niswander
Overview
Explore the profile of Lisa M Niswander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balestra T, Niswander L, Bagashev A, Loftus J, Ross S, Chen R, et al.
Leukemia
. 2024 Dec;
39(3):555-567.
PMID: 39681640
CRLF2 rearrangements occur in >50% of Ph-like and Down syndrome (DS)-associated B-acute lymphoblastic leukemia (ALL) and induce constitutive kinase signaling targetable by the JAK1/2 inhibitor ruxolitinib under current clinical investigation....
2.
Niswander L, Chung P, Diorio C, Tasian S
Haematologica
. 2023 Apr;
108(11):3142-3147.
PMID: 37021525
No abstract available.
3.
Niswander L, Graff Z, Chien C, Chukinas J, Meadows C, Leach L, et al.
Haematologica
. 2022 Aug;
108(2):457-471.
PMID: 35950535
Chimeric antigen receptor (CAR) T-cell immunotherapies targeting CD19 or CD22 induce remissions in the majority of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), although relapse due to target antigen...
4.
Qin H, Yang L, Chukinas J, Shah N, Tarun S, Pouzolles M, et al.
J Immunother Cancer
. 2021 Sep;
9(9).
PMID: 34531250
Background: Successful development of chimeric antigen receptor (CAR) T cell immunotherapy for children and adults with relapsed/refractory acute myeloid leukemia (AML) is highly desired given their poor clinical prognosis and...
5.
Niswander L, Loftus J, Lainey E, Caye-Eude A, Pondrom M, Hottman D, et al.
Haematologica
. 2021 Jul;
106(10):2763-2767.
PMID: 34196168
No abstract available.
6.
Loftus J, Yahiaoui A, Brown P, Niswander L, Bagashev A, Wang M, et al.
Haematologica
. 2020 May;
106(4):1067-1078.
PMID: 32414848
Survival of infants with KMT2A-rearranged (R) acute lymphoblastic leukemia (ALL) remains dismal despite intensive chemotherapy. We observed constitutive phosphorylation of spleen tyrosine kinase (SYK) and associated signaling proteins in infant...
7.
Niswander L, Palis J, McGrath K
Methods Mol Biol
. 2016 Jul;
1389:265-77.
PMID: 27460252
In light of the indispensible role of platelets in the maintenance of hemostasis, understanding the biology of platelet production from bone marrow megakaryocytes (MKs) may uncover new therapeutic strategies for...
8.
Niswander L, Fegan K, Kingsley P, McGrath K, Palis J
Blood
. 2014 Apr;
124(2):277-86.
PMID: 24735964
Megakaryocyte (MK) development in the bone marrow progresses spatially from the endosteal niche, which promotes MK progenitor proliferation, to the sinusoidal vascular niche, the site of terminal maturation and thrombopoiesis....
9.
Niswander L, Cromwell P, Chirico J, Gupton A, Korones D
J Palliat Med
. 2014 Mar;
17(5):589-91.
PMID: 24628107
Background: Despite recent strides in pediatric palliative care (PPC), there are few published data on community-based care of dying children. Objective: Our aim was to describe end-of-life care during the...
10.
Niswander L, McGrath K, Kennedy J, Palis J
Cytometry A
. 2014 Mar;
85(4):302-12.
PMID: 24616422
Life-threatening thrombocytopenia can develop following bone marrow injury due to decreased platelet production from megakaryocytes (MKs). However, the study of primary MKs has been complicated by their low frequency in...